Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Researchers from Yale University have found that while engaging with social information, children with autism spectrum disorders experienced enhanced brain activity after a single dose of the hormone oxytocin was administered through a nasal spray.
Results of their findings are published in the journal Proceedings of the National Academy of Sciences.
Oxytocin is a naturally occurring hormone in the human body that has been implicated in social bonding. In fact, other research recently found that oxytocin stimulates the reward center in the brain, increasing partner attractiveness and strengthening monogamy.
According to the researchers from Yale, theirs is the first study to analyze how oxytocin affects brain function in children with autism spectrum disorders (ASDs).
Led by study author Ilanit Gordon, the team conducted a double-blind, placebo-controlled experiment involving 17 children and adolescents with ASDs who were between the ages of 8 and 16.5.
After the participants were given either the oxytocin spray or a placebo, the researchers measured brain activity via functional magnetic resonance imaging (MRI) while the children and adolescents judged both socially and non-socially meaningful pictures.
The "social" pictures were images of eyes, whereas the "non-social" pictures were images of vehicles.
Because autism is a result of a neurological disorder that affects normal brain function, individuals with ASD have difficulty with communication and social interaction skills.
How the brains of these individuals react to socially meaningful images is therefore helpful for treatments that "target the core social dysfunction in ASD," the researchers note.
The team found that, compared with the placebo group, the participants who received a single nasal dose of oxytocin experienced enhanced activity in the brain.
Ilanit Gordon explains further:
"We found that brain centers associated with reward and emotion recognition responded more during social tasks when children received oxytocin instead of the placebo. Oxytocin temporarily normalized brain regions responsible for the social deficits seen in children with autism."
She adds that the oxytocin assisted social attunement - a process whereby brain regions involved with social behavior and cognition are activated more for social stimuli and less for non-social stimuli.
The researchers say that the neural attunement they observed "might facilitate social learning, thus bringing about long-term change in neural systems and subsequent behavioral improvements."
"Our results are particularly important considering the urgent need for treatments to target social dysfunction in autism spectrum disorders," Gordon concludes.
Written by Marie Ellis
Copyright: Medical News Today
Not to be reproduced without the permission of Medical News Today.
Oxytocin enhances brain function in children with autism, Ilanit Gordon, et al., PNAS, doi: 10.1073/pnas.1312857110, published online 2 December 2013, Abstract.
Yale University Release, accessed 3 December 2013.
Visit our Autism category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Ellis, Marie. "Oxytocin activates 'social' brain regions in children with autism." Medical News Today. MediLexicon, Intl., 3 Dec. 2013. Web.
19 Apr. 2014. <http://www.medicalnewstoday.com/articles/269630>
Ellis, M. (2013, December 3). "Oxytocin activates 'social' brain regions in children with autism." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/articles/269630.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT is the registered trade mark of MediLexicon International Limited.